Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For VRNS
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -4.77 2.38 2.50
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 78.17 -3.38 -15.47
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -8.44 4.11 4.49
Cash 1.77 4.98 4.90
Capex 86.33 < 0.005 -0.02
Free Cash Flow 574.33 0.51 0.08
Revenue -26.67 1.04 1.41
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -7.05 0.81 0.87
Operating Margin -1211.18 -0.45 -0.03
ROA 680.81 -0.04 < 0.005
ROE 706.71 -0.09 0.01
ROIC 60.72 -0.07 -0.19
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of VRNS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of VRNS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of VRNS is permitted for members.